Neoacrimarine I(217199-07-0)
- Name: Neoacrimarine I
- Synonyms:Neoacrimarine I;Neoacrymarine I;(-)-Neoacrimarine-I;1-hydroxy-5-({13-hydroxy-12,12-dimethyl-4-oxo-3,11-dioxatricyclo[8.4.0.0^{2,7}]tetradeca-1,5,7,9-tetraen-14-yl}oxy)-3,6-dimethoxy-9,10-dihydroacridin-9-one
- Molecular Formula:C29H25NO9
- Molecular Weight:531.5
- CAS Registry Number:217199-07-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 159156-96-4/Tert-butyl (2-(2-((((2,5-dioxopyrrolidin-1-YL)oxy)carbonyl)oxy)ethoxy)ethyl)carbamate
- 99718-69-1/2-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]isoindolin-1-one
- 207602-26-4/Clauslactone K
- 210169-06-5/2,3-Dibromo-5,6,7,8-tetrafluoroquinoxaline
- 193148-61-7/4,5-Bis(4-chlorobutylsulfanyl)-1,3-dithiole-2-thione
- 219948-37-5/12,15-Heneicosadien-4-one, 2-(acetyloxy)-1-hydroxy-, (2R,12Z,15Z)-
- 171438-25-8/3-Hydroxy-15,16,17-trimethoxytricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaene-8,9-dione
- 144989-52-6/1H-Indole-2-carboxylic acid, 4,6-dichloro-3-[3-oxo-3-[(phenylmethyl)amino]-1-propenyl]-, (E)-
- 144689-67-8/1-[(2'-Carboxy-1,1'-biphenyl-4-yl)methyl]-2-ethyl-4-(1-hydroxy-1-methylethyl)-1H-imidazole-5-carboxylic acid
- 66891-12-1/Methyl 6-palmitoyl-beta-D-glucopyranoside
- 758676-50-5/1-[4-(2-Hydroxyethyl)piperazinocarbonyl]-3-(alpha-hydroxy-2-thenylidene)-5-chloro-1H-indole-2(3H)-one
- 129732-91-8/3-(3-O,5-O-Diphosphono-2-deoxy-beta-D-ribofuranosyl)-3H-imidazo[2,1-i]purine
- 283174-66-3/Walsuranolide
- 759444-32-1/(R)-1-{2-[Bis-(2-chloro-phenyl)-methyleneaminooxy]-ethyl}-piperidine-3-carboxylic acid; hydrochloride
- 157429-43-1/1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-4-methyl-7-oxo-3-[(5-oxo-3-pyrrolidinyl)thio]-, (4-nitrophenyl)methyl ester, [4R-[3(R*),4alpha,5beta,6beta(R*)]]-
- 250384-79-3/5-((2E)-((3aS,7aS)-1-((1R)-3-((1,1-Dimethylethyl)sulfonyl)-1-methylpropyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol, (1R,3S,5Z)-
- 82396-51-8/1-(Heptadecafluorooctyl)-4-methylbenzene
- 291533-29-4/2-(4''-Bromo-biphenyl-4-sulfonylamino)-6-phenoxy-hex-4-ynoic acid
- 218916-53-1/Euphorbia factor L8
- 217199-07-0/Neoacrimarine I
- 178330-56-8/Epomusenin B
- 247235-80-9/(S)-2-[[2'-Methyl-5-[[[(thiazole-5-yl)methyl](3,5-difluorobenzyl)amino]methyl]-2-biphenylyl]carbonylamino]-4-(methylthio)butyric acid
- 221695-66-5/Ergosta-5,24-dien-26-oic acid, 14,20-epoxy-3-(beta-D-glucopyranosyloxy)-17,22-dihydroxy-1-oxo-, delta-lactone, (3beta,17alpha,22R)-
- 340270-88-4/ginsenoside Rh5
- 164642-39-1/(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-(2-phenylmethoxyethyl)-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
- 209903-43-5/(24Z)-3beta-[(6-O-Palmitoyl-beta-D-glucopyranosyl)oxy]-5alpha-stigmasta-5,24(28)-diene
- 245724-10-1/2-Acetyl-3-methyl-6-methoxy-8-[6-O-[3-O-(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]-beta-D-glucopyranosyloxy]-1-naphthol
- 239088-24-5/[(2R)-3-[[(2R)-1-[[(2S,5S,8S,11R,12S,15S,18S,21R)-5-benzyl-2,8-bis[(2S)-butan-2-yl]-21-hydroxy-15-[2-(4-hydroxyphenyl)ethyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(4-hydroxyphenyl)-1-oxobutan-2-yl]amino]-2-methoxy-3-oxopropyl] hydrogen sulfate
- 171527-64-3/Brevetoxin B3 C66 component
- 252979-60-5/beta-D-Glucopyranosiduronic acid, (3beta,16alpha)-28-[(O-beta-D-glucopyranosyl-(1-->3)-O-beta-D-xylopyranosyl-(1-->3)-O-[beta-D-xylopyranosyl-(1-->4)]-O-6-deoxy-alpha-L-mannopyranosyl-(1-->2)-alpha-L-arabinopyranosyl)oxy]-16-hydroxy-28-oxoolean-12-en-3-yl